1995
DOI: 10.1172/jci117897
|View full text |Cite
|
Sign up to set email alerts
|

Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.

Abstract: Integrin avj83 is a marker of progression in malignant melanoma. Previously we reported that human melanoma cells derived from regional lymph node metastases had increased a483-mediated adhesion to lymph node vitronectin. In the present study, the expression and function of tvf33 were further investigated with emphasis on the functional relationship between a433 and the urokinase-type plasminogen activator system of proteolysis. We found that metastasesderived melanoma MeWo LNI 61 (61) and MIM/8 LNI cells had … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
25
0
1

Year Published

1996
1996
2008
2008

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 77 publications
(27 citation statements)
references
References 37 publications
(24 reference statements)
1
25
0
1
Order By: Relevance
“…Secondly, the binding site can internalize urokinase that is covalently linked to its physiological inhibitor PAI-1 . Thirdly, the receptor can interact with vitronectin thereby modulating cellular adhesion (Wei et al, 1994;Nip et al, 1995).…”
Section: Introductionmentioning
confidence: 99%
“…Secondly, the binding site can internalize urokinase that is covalently linked to its physiological inhibitor PAI-1 . Thirdly, the receptor can interact with vitronectin thereby modulating cellular adhesion (Wei et al, 1994;Nip et al, 1995).…”
Section: Introductionmentioning
confidence: 99%
“…In melanoma, for example, the expression of avP3 correlates with invasiveness (Gehlsen et al, 1992) and there is a correlation between avP3 and tumorigenic capacity (Marshall et al, 1991;Marshall and Hart, 1996). Recently, there has been evidence of a close functional inter-relationship between members of the av subfamily and the uPA/uPAR proteolytic system (Nip et al, 1995;Stefansson and Lawrence, 1996;Yebra et al, 1996). This is of particular interest in breast cancer in which uPA (Duffy et al, 1990) and uPAR expression have been shown to correlate with prognosis (Duggan et al, 1995).…”
mentioning
confidence: 99%
“…A 1.3-kb BamH1 CathL cDNA fragment and a 1.5-kb EcoRI-18S cDNA fragment were obtained from the pCDNA3-CathL and pCDNA3.1-18S (a gift from Dr Shafaat Rabani, McGill University, Montreal, Quebec, Canada) plasmids, respectively. The DNA fragments were recovered from agarose gel, labelled with [a-32 P]dCTP using the ReadyTo-Go DNA Labelling Beads (GE Healthcare, Baie D'Urfe, Quebec, Canada), as per the manufacturer's instructions and used to hybridize the membranes as we described previously (Nip et al, 1995;Long et al, 1998).…”
Section: Plasmids and Transfectionmentioning
confidence: 99%